Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Jun 2018 07:00 AM
RNS
Positive Results for Phase IIb FLU-v Field Study
06 Jun 2018 04:55 PM
RNS
Notice of AGM & Posting of Annual Report&Accounts
23 May 2018 12:30 PM
RNS
Result of AGM
17 May 2018 07:00 AM
RNS
Final Results
27 Apr 2018 02:00 PM
RNS
2017 Annual Report and Financial Statements
23 Apr 2018 07:00 AM
RNS
Notice of Results
19 Apr 2018 07:01 AM
RNS
Audited 2017 Preliminary Results
19 Apr 2018 07:00 AM
RNS
Chief Executive Officer Steps Down
10 Apr 2018 07:00 AM
RNS
Statement regarding share price
06 Apr 2018 07:00 AM
RNS
Notice of Preliminary Results
05 Apr 2018 12:00 PM
RNS
Directors' Dealings
26 Mar 2018 07:00 AM
RNS
Initial results from a Phase IIb study of FLU-v
21 Mar 2018 07:00 AM
RNS
Directorate Change
15 Feb 2018 07:00 AM
RNS
Trading Statement
25 Jan 2018 07:00 AM
RNS
Change of Adviser
23 Jan 2018 07:00 AM
RNS
Acquisition of Minority Interest
16 Jan 2018 07:00 AM
RNS
Award of Share Options
09 Jan 2018 07:00 AM
RNS
Directors' Dealings
21 Dec 2017 07:00 AM
RNS
Award of Share Options
14 Dec 2017 02:00 PM
RNS
Director's Dealings
30 Oct 2017 07:00 AM
RNS
Directorate Change
05 Oct 2017 07:00 AM
RNS
Directors' Dealings
21 Sep 2017 07:00 AM
RNS
Half-year Report
14 Sep 2017 05:19 PM
RNS
Grant of Stock Options
12 Sep 2017 07:00 AM
RNS
Half-year Report
25 Jul 2017 07:00 AM
RNS
Senior Management Appointment
20 Jul 2017 07:00 AM
RNS
Half year end update
10 Jul 2017 07:00 AM
RNS
Directors' Dealings
20 Jun 2017 07:00 AM
RNS
Board Change
24 May 2017 02:00 PM
RNS
Result of Annual General Meeting
18 May 2017 07:00 AM
RNS
Award of Deferred Bonus Share Options
28 Apr 2017 02:00 PM
RNS
2016 Annual Report and Financial Statements
26 Apr 2017 06:01 PM
RNS
Result of AGM
25 Apr 2017 03:13 PM
RNS
Proposed amendment to AGM resolution
20 Apr 2017 07:00 AM
RNS
Audited 2016 Preliminary Results
13 Apr 2017 07:00 AM
RNS
Trading Update
05 Apr 2017 07:00 AM
RNS
Directors' Dealings
05 Apr 2017 07:00 AM
RNS
Integumen IPO
31 Mar 2017 11:26 AM
RNS
Annual Financial Report & Notice of AGM
29 Mar 2017 01:57 PM
RNS
Issue of Equity
22 Mar 2017 07:00 AM
RNS
Final Results
03 Mar 2017 07:00 AM
RNS
Year End Update
21 Feb 2017 04:30 PM
RNS
Initiation of a Phase I clinical trial with AGS-v
09 Feb 2017 07:00 AM
RNS
Data from PrEP Biopharm's Ph. IIa clinical studies
05 Jan 2017 07:00 AM
RNS
Directors' Dealings
30 Dec 2016 07:00 AM
RNS
Change of auditor
18 Nov 2016 07:00 AM
RNS
Completion of Sale
10 Nov 2016 05:51 PM
RNS
REPLACEMENT - Contract win
08 Nov 2016 07:00 AM
RNS
Contract win
02 Nov 2016 07:03 AM
RNS
Director/PDMR Shareholding

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings